Prognostic Value of Preoperative Serum Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 After Resection of Ampullary Cancer

J Gastrointest Surg. 2017 Nov;21(11):1775-1783. doi: 10.1007/s11605-017-3489-8. Epub 2017 Sep 5.

Abstract

Background: The purpose of this study is to investigate the prognostic value of pre-resection serum carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9 after resection of ampullary cancer (AC) in consideration of intestinal (IT) and pancreatobiliary (PT) subtypes.

Methods: Overall survival (OS) analysis of patients undergoing curative resection of ampullary cancer.

Results: Elevated preoperative CEA (P = 0.013) and CA 19-9 levels (P = 0.030) were significant prognostic factors. Subgroup analysis, however, showed both markers having prognostic value only for the IT subgroup. Pre-resection CEA within normal range identified a subgroup of IT patients with an excellent median survival of 145 months. Compared to other AC patients, this low-risk ITCEA- subpopulation was characterized by less frequent advanced pT stages (pT3/pT4, 41 vs. 62%; P = 0.047) and lymph node involvement (pN+, 30 vs. 65%; P = 0.001). OS of this subgroup was significantly better compared to other AC patients (145 vs. 25 months; HR = 3.8; P < 0.001). By multivariate survival analysis, the patient age, the PT subtype, and an elevated pre-resection serum CEA value were identified as independent prognostic variables.

Conclusions: In AC, the histomorphologic subclassification is highly relevant regarding the prognostic value of preoperative serum CEA and CA 19-9. IT-patients with normal preoperative CEA represent a favorable subgroup with excellent long-term survival.

Keywords: Ampullary cancer; CA 19-9; CEA; Intestinal; Pancreaticobiliary.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Ampulla of Vater*
  • CA-19-9 Antigen / blood*
  • Carcinoembryonic Antigen / blood*
  • Cohort Studies
  • Common Bile Duct Neoplasms / blood*
  • Common Bile Duct Neoplasms / mortality
  • Common Bile Duct Neoplasms / surgery*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Predictive Value of Tests
  • Prognosis
  • Risk Factors
  • Survival Analysis

Substances

  • CA-19-9 Antigen
  • Carcinoembryonic Antigen